Randomized, parallel, comparison, double-blind efficacy and safety study of Aprovel (irbesartan) versus placebo in Chinese patients with hypertensive type II diabetic patients with microalbuminuria
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Irbesartan (Primary)
- Indications Diabetic nephropathies; Hypertension; Proteinuria
- Focus Therapeutic Use
- Acronyms PRIME
- Sponsors Sanofi
- 04 Dec 2007 New trial record.